IFNG and vitiligo: This study provides strong evidence that treatment with the fully human monoclonal IFN-γ antibody EI-001 alone effectively inhibits IFN-γ-induced melanocyte damage, restores melanin production, and holds great potential for vitiligo therapy [217].